Ark Therapeutics completes potency test qualification enabling ... - RTT News PDF Print

... safety of Trinam will be investigated in patients with end-stage renal disease (ESRD) requiring vascular access for haemodialysis. by RTT Staff Writer.

read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.